Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular Carcinoma

被引:7
|
作者
Agirre-Lizaso, Alona [1 ]
Huici-Izagirre, Maider [1 ]
Urretabizkaia-Garmendia, Josu [1 ]
Rodrigues, Pedro M. [1 ,2 ,3 ]
Banales, Jesus M. [1 ,2 ,3 ,4 ]
Perugorria, Maria J. [1 ,2 ,5 ]
机构
[1] Univ Basque Country, Donostia Univ Hosp, Biodonostia Res Inst, Dept Liver & Gastrointestinal Dis,UPV EHU, Donostia San Sebastian 20014, Spain
[2] Inst Salud Carlos III ISCIII, Ctr Study Liver & Gastrointestinal Dis CIBERehd, Madrid 28029, Spain
[3] Basque Fdn Sci, IKERBASQUE, Bilbao 48009, Spain
[4] Univ Navarra, Sch Sci, Dept Biochem & Genet, Pamplona 31008, Spain
[5] Univ Basque Country, Fac Med & Nursing, Dept Med, UPV EHU, Donostia San Sebastian 20014, Spain
关键词
liver cancer; hepatocellular carcinoma; immunotherapy; tumour microenvironment; tumour-associated macrophages; innate immune system; macrophage reprogramming; EPITHELIAL-MESENCHYMAL TRANSITION; LIVER MACROPHAGES; DOUBLE-BLIND; C/EBP-ALPHA; CELLS; SORAFENIB; PROMOTE; GROWTH; MICROENVIRONMENT; POLARIZATION;
D O I
10.3390/cancers15204977
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Hepatocellular carcinoma (HCC) is a highly lethal disease with an increasing incidence. Despite the advancements in diagnosis and recent therapeutic options, improving the prognosis of HCC patients remains challenging. One of the reasons of the unsatisfactory outcome of patients with HCC is the complex tumour microenvironment (TME), which is composed of immune and stromal cells, limiting effective treatments. Recent research has highlighted the importance of macrophages in the development and progression of HCC, opening new possibilities for therapy. This review focuses on the heterogeneity of tumour-associated macrophages (TAMs) in HCC, the mechanisms through which HCC tumour cells polarize macrophages, and the therapeutic targets that are currently being tested to explore novel therapies that can improve the prognosis and quality of life of HCC patients.Abstract Hepatocellular carcinoma (HCC) is a prevalent and aggressive cancer that comprises a complex tumour microenvironment (TME). Tumour-associated macrophages (TAMs) are one of the most abundant immune cells present in the TME, and play a key role both in the development and in the progression of HCC. Thus, TAM-based immunotherapy has been presented as a promising strategy to complement the currently available therapies for HCC treatment. Among the novel approaches focusing on TAMs, reprogramming their functional state has emerged as a promising option for targeting TAMs as an immunotherapy in combination with the currently available treatment options. Nevertheless, a further understanding of the immunobiology of TAMs is still required. This review synthesizes current insights into the heterogeneous nature of TAMs in HCC and describes the mechanisms behind their pro-tumoural polarization focusing the attention on their interaction with HCC cells. Furthermore, this review underscores the potential involvement of TAMs' reprogramming in HCC therapy and highlights the urgency of advancing our understanding of these cells within the dynamic landscape of HCC.
引用
收藏
页数:20
相关论文
共 50 条
  • [1] Targeting tumor associated macrophages in hepatocellular carcinoma
    Xu, Wenqian
    Cheng, Yuliang
    Guo, Yahui
    Yao, Weirong
    Qian, He
    BIOCHEMICAL PHARMACOLOGY, 2022, 199
  • [2] Tumour-associated macrophages: versatile players in the tumour microenvironment
    Ji, Zoey Zeyuan
    Chan, Max Kam-Kwan
    Chan, Alex Siu-Wing
    Leung, Kam-Tong
    Jiang, Xiaohua
    To, Ka-Fai
    Wu, Yi
    Tang, Patrick Ming-Kuen
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [3] Epigenetic tuning of tumour-associated macrophages (TAMs): a potential approach in hepatocellular carcinoma (HCC) immunotherapy
    Helal, Israa M.
    Kamal, Monica A.
    Abd El-Aziz, Mostafa K.
    El Tayebi, Hend M.
    EXPERT REVIEWS IN MOLECULAR MEDICINE, 2024, 26
  • [4] Irreversible repolarization of tumour-associated macrophages by low-Pi stress inhibits the progression of hepatocellular carcinoma
    Lv, Yang-feng
    Liao, Zi-qiang
    Bi, Qiu-chen
    Xie, Chuan-sheng
    Wei, Xiao-yong
    Yun, Yi
    He, Yuan-qiao
    Tang, Qun
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2023, 27 (19) : 2906 - 2921
  • [5] Tumour-Associated Macrophages in Oral Squamous Cell Carcinoma
    Chaurasia, Akhilanand
    Brigi, Carel
    Daghrery, Arwa
    Asa'ad, Farah
    Spirito, Francesca
    Hasuike, Akira
    Gonzalez-Alva, Patricia
    Kojic, Dave D.
    Unsal, Revan Birke Koca
    Sivaramakrishnan, Gowri
    ORAL DISEASES, 2025,
  • [6] Biology and therapeutic targeting of tumour-associated macrophages
    Beltraminelli, Tim
    De Palma, Michele
    JOURNAL OF PATHOLOGY, 2020, 250 (05) : 573 - 592
  • [7] Molecular Repolarisation of Tumour-Associated Macrophages
    van Dalen, Floris J.
    van Stevendaal, Marleen H. M. E.
    Fennemann, Felix L.
    Verdoes, Martijn
    Ilina, Olga
    MOLECULES, 2019, 24 (01):
  • [8] Targeting Tumour-Associated Fibroblasts in Cancers
    Shah, Kairav
    Mallik, Sanchari Basu
    Gupta, Praveer
    Iyer, Abishek
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [9] Regulation of intrinsic and extrinsic metabolic pathways in tumour-associated macrophages
    Davuluri, Goutham Venkata Naga
    Chan, Chia-Hsin
    FEBS JOURNAL, 2023, 290 (12) : 3040 - 3058
  • [10] Macrophages and hepatocellular carcinoma
    Tian, Zhiqiang
    Hou, Xiaojuan
    Liu, Wenting
    Han, Zhipeng
    Wei, Lixin
    CELL AND BIOSCIENCE, 2019, 9 (01)